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The diuretic drug amiloride antagonises the insulin-dependent increase in phosphorylation of ATP-citrate 
lyase in hepatocytes i olated from rats that had been starved and refed a fat-free diet. Studies with a range 
of protein kinases and protein phosphatases that ve been shown to phosphorylate or dephosphorylate 
purified ATP-citrate lyase in vitro revealed that amiloride was a non-specific inhibitor of all protein 
kinases tested, but did not significantly affect any of the protein phosphatases. These results cast doubt 
on previous claims that growth factors stimulate phosphorylation of ribosomal protein S6 by activating 
an amiloride-sensitive Na+/H+ exchange system, and that insulin inhibits a protein phosphatase that is 
activated by amiloride. 
Insulin Protein phosphorylation 
1. INTRODUCTION 
Insulin increases the phosphorylation of several 
proteins in isolated cells or cell culture systems, in- 
cluding ATP-citrate lyase [ 1,2], ribosomal protein 
S6 [3-51 and an unidentified rat liver polypeptide 
of M, 46000 [6,7]. Recently it has been reported 
that the diuretic drug amiloride* opposes the f- 
fects of serum or insulin on ribosomal protein S6 
in CC1 39 cells [8] and on the M, 46 000 polypeptide 
in isolated hepatocytes [9]. These effects have been 
interpreted as showing that growth-factor activa- 
tion of S6 phosphorylation in CC139 cells is trig- 
gered by stimulation of Na+/H+ exchange in the 
plasma membrane, and that insulin inhibits an 
amiloride-stimulated protein phosphatase in 
isolated hepatocytes. To investigate the action of 
amiloride further, we studied the phosphorylation 
+ To whom correspondence should be addressed 
* Amiloride (N-amidino-3,5-diamino-6-chloropyrazine- 
carboxamide) is a potassium-sparing diuretic, its 
diuretic effect being thought to be due to inhibition of 
Na’ uptake via Na+/H+ exchange in the kidney tubule 
Amiloride Protein kinase 
of ATP-citrate lyase, since both the protein kinases 
[lo-121 and protein phosphatases [13] acting on 
this protein are well characterised. Our results 
show that amiloride is a non-specific inhibitor of 
protein kinase activity and cast doubt on the inter- 
pretation of the previous studies discussed above. 
2. METHODS 
Collagenase (type 1) casein and ovalbumin were 
from Sigma Chemicals; pyruvate kinase and ATP 
were from Boehringer; bovine serum albumin 
(fraction V) was from BDH Chemicals and was 
defatted as in [14]; [y-32P]ATP was from Amers- 
ham International; rat mammary acetyl-CoA car- 
boxylase [15] and ATP-citrate lyase [ll] were 
purified as described. Rabbit skeletal muscle 
glycogen synthase was purified as in [16]. 
Protein phosphatases 1,2A and 2C were assayed 
using [32P]phosphorylase a or [32P]phosphorylase 
kinase as in [ 171. Protein phosphatases 1 and 2A 
were purified to homogeneity from rabbit skeletal 
muscle [T. Resink, B.A. Hemmings, H.Y. Lim 
Tung and P. Cohen (1983) submitted] and protein 
phosphatase 2C purified as far as the Sephadex 
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G-200 step from rat liver as in [ 131. Cyclic AMP- 
dependent protein kinase, phosphorylase kinase, 
calmodulin-dependent glycogen synthase kinase, 
and glycogen synthase kinases -3, -4 and -5 were 
isolated from rabbit skeletal muscle and assayed as 
in [ 161. Casein kinase-1 was purified from rat 
mammary gland by ammonium sulphate precipita- 
tion and chromatography on phosphocellulose and 
Sephadex G-200 [M.R. Munday and D.G.H. 
(1983) in preparation]. It was assayed in 50 ~1 final 
vol. using casein (2 mg/ml), EGTA (0.1 mM), 
EDTA (2 mM), Mg acetate (6 mM), sodium 
glycerophosphate (20 mM), [y-32P]ATP (0.2 mM; 
28000 cpm/nmol) (pH 7.0). Incorporation of 
radioactivity into protein was determined as in 
1111. 
Hepatocytes were isolated as in [18] from male 
Sprague-Dawley rats (150-250 g) which had been 
starved for 72 h and refed for 48 h (fat-free diet, 
ICN Nutritional Biochemicals). Cells were in- 
cubated in minimal essential medium with addi- 
tions as in [6] at -10’ cells/ml. Where added, in- 
sulin was at 10e8 M and amiloride at 1 mM. In 
32P-labelling experiments cells were incubated in 
non-radioactive medium (1.2 mM phosphate) for 
30 min and were then harvested and resuspended 
in medium containing [32P]phosphate (0.2 mM; 
0.625 Ci/mmol) and incubation continued for 
60 min before addition of insulin or amiloride. 
Cells used for protein phosphatase assays were pre- 
incubated for 90 min as for 32P-labelling ex- 
periments except that unlabelled phosphate 
(1.2 mM) was used throughout. Cells were 
homogenised using 40 strokes of a Dounce 
homogeniser in 0.25 ml/ml cell suspension of 
either: (a) 50 mM Tris-Cl- (pH 7.5), 2 mM 
EDTA, 10 mM 2-mercaptoethanol, 100 mM NaF, 
0.25 M sucrose, plus protease inhibitors as in [15] 
(for experiment shown in fig.1); or (b) 50 mM 
Tris-Cl- (pH 7.0), 4 mM EDTA, 0.1% (v/v) 
2-mercaptoethanol, 0.25 M sucrose (for ex- 
periments involving protein phosphatase assays or 
studies of dephosphorylation). 
3. RESULTS 
3.1. Effect of amiloride on 32P-labelling of 
cytosolic proteins in isolated hepatocytes 
To examine the effects of amiloride on 
phosphorylation of ATP-citrate lyase, hepatocytes 
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were isolated from rats which had been starved for 
72 h and then refed a fat-free diet, a procedure 
which causes a large increase in the amount of 
ATP-citrate lyase protein [l]. If amiloride was 
added at the beginning of the 60 min 32P-labelling 
period, it substantially reduced the labelling of all 
cytosolic proteins (fig.1). If cells were labelled for 
60 min and then resuspended in non-radioactive 
medium with or without insulin (10-s M) or 
amiloride (1 mM), insulin caused an increase, and 
amiloride a decrease, in the labelling of polypep- 
tides of M, 116000 and 46000 (fig.1). The M, 
Fig.1. Effects of insulin and amiloride on 32P-labelling 
of cytosolic proteins in isolated hepatocytes during a 
chase with non-radioactive medium. Cells were “P- 
labelled for 60 min as in section 2. The photograph 
shows an autoradiogram after electrophoresis of 
supernatant fractions (100000 x g; 60 min) in an 
SDS-7% polyacrylamide gel 1201. The left-hand track 
shows a sample of cells homogenised at the end of the 
labelling period. The 9 central tracks show samples 
homogenised at the times indicated (minutes) after 
resuspension in non-radioactive medium in the presence 
of: (C) no additions; (A) amiloride; (I) insulin. The 
right-hand 2 tracks show the effect of including 
amiloride during the 60 min labelling period: (C) no 
addition; (A) amiloride. Arrows at left mark the 
migration positions of marker proteins: rat mammary 
acetyl-CoA carboxylase (240000, [15]), rat mammary 
ATP-citrate lyase (116000, [lo]), rabbit muscle 
phosphorylase b (98000, [21]), bovine serum albumin 
(68000, [22]), rabbit muscle pyruvate kinase (56000, 
[23]), and hen egg ovalbumin (45000, [24]). 
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Table 1 
Effect of amiloride and insulin on protein phosphatases 1, 2A and 2C 
Type of preparation Protein Amiloride (1 mM) Amiloride (0.1 mM) Insulin (10M8 M) 
phosphatase (070 control) (vo control) (Yo control) 
Purified phosphatase 1 84 f 4(2) 104 * 4(2) - 
2A 90 + 4(2) 102 * 3(2) - 
2c 87 + l(2) 95 + l(2) - 
Liver homogenate 1 104(l) - - 
2A 97(l) - - 
Intact isolated hepatocytes 1 98 + 20(4) - 104 + 18(13) 
2A 91 f 4(11) _ 114 + 7(25) 
2c 97 + 5(5) - 91 + lO(5) 
Results are expressed as mean * standard error of the mean for the number of paired experiments hown in brackets. 
In cell-free experiments the enzyme sample was preincubated with amiloride for 5 min at 30°C before starting the 
reaction with [32P]substrate. In intact cell experiments cells were treated with or without amiloride or insulin for 15 min 
and then homogenates were prepared for protein phosphatase assays 
116000 polypeptide comigrates with the subunit of 
purified rat mammary ATP-citrate lyase (fig. l), is 
greatly elevated on starving and refeeding, and has 
been identified as ATP-citrate lyase in several 
laboratories [ 1,2]. 
3.2. Effects of amiloride and insulin on protein 
phosphatase activities 
Protein phosphatase activity dephosphorylating 
Table 2 
Effect of amiloride or. protein kinase activities 
Protein kinase Amiloride Activity 
(mM) (Yo control) 
1. Cyclic AMP-dependent 
protein kinase 0.1 40 
2. Calmodulin-dependent 
glycogen synthase kinase 0.1 47 
3. Phosphorylase kinase 0.1 45 
4. Glycogen synthase 
kinase-3 0.1 47 
5. Glycogen synthase 
kinase-4 0.1 60 
6. Glycogen synthase 
kinase-5 0.1 75 
7. Casein kinase I 1.0 56 
Protein kinases l-6 were assayed using glycogen 
synthase as substrate (0.4 mg/ml) and 0.1 mM ATP as 
in [16]; casein kinase I was assayed as in section 2 
[32P]ATP-citrate lyase in rat liver cytosol is ac- 
counted for by 3 enzymes: protein phosphatase 1, 
2A and 2C [ 13). Therefore, we tested the effects of 
amiloride on the activity of these 3 protein 
phosphatases in a variety of experimental systems 
(table 1). The only significant effect observed was 
a slight inhibition of the purified enzymes by 
1 mM amiloride. Addition of 1 mM amiloride to a 
liver homogenate also had no significant effect on 
the dephosphorylation of ATP-citrate lyase, the 
A4, 46000 phosphoprotein or any other 
phosphoprotein detectable by autoradiography 
after SDS-polyacrylamide gel electrophoresis (not 
shown). Neither insulin nor amiloride, when added 
directly to isolated hepatocytes, had any signifi- 
cant effect on any of the protein phosphatases as 
judged by assays in extracts prepared from the cells 
(table 1). 
3.3. Effect of amiloride on protein kinase 
activities in vitro 
The effect of amiloride on a wide range of 
homogeneous or partially purified protein kinases 
is shown in table 2. All were inhibited by ami- 
loride. Experiments with the catalytic subunit of 
cyclic AMP-dependent protein kinase showed that 
the inhibition was competitive with respect to 
ATP, being relieved if ATP concentration was in- 
creased (not shown). 
271 
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4. DISCUSSION 
These results show that the reported antagonism 
between amiloride and insulin also extends to 
ATP-citrate lyase. On the basis of experiments 
with hepatocytes isolated from rats fed ad Iibitum, 
it was proposed [9] that amiloride activates an 
insulin-sensitive protein phosphatase. Our data do 
not support this hypothesis. The conclusions [9] 
were based on the observation that the effects of 
insulin and amiloride were preserved in cells that 
had been chased with non-radioactive medium. 
However, this result can only rule out the possibili- 
ty that insulin and/or amiloride act on protein 
kinase activity if the specific radioactivity of the y- 
phosphate of intra~ellul~ ATP decreases very 
rapidly during the chase. The results of our 
pulse-chase experiment suggest that this is not the 
case. There is very little loss of 32P from cytosolic 
proteins during a 60 min chase and in the presence 
of insulin the 32P-labelling of ATP-citrate lyase 
and the Mr 46000 polypeptide actually increase 
during the chase (fig.1). 
In isolated hepatocytes ATP-citrate lyase is 
phosph~rylated exclusively at the same site 
phosphorylated on the purified enzyme by cyclic 
AMP-dependent protein kinase in vitro [12,t9], 
The protein phosphatase activity dephosphoryla~- 
ing this site in rat liver cytosol is accounted for by 
protein phosphatases 1,2A and 2C 1131. This gave 
us the opportunity to test directly the hypothesis 
[9] that amiloride activates a protein phosphatase. 
No evidence could be found for activation of any 
protein phosphatase which acts on ATP-citrate 
lyase (table 1). 
An alternative explanation for the data in fig.1 
is that amiloride inhibits ATP-citrate lyase kinase 
activity. While the protein kinase(s) responsible for 
phosphorylation of ATP-citrate fyase under basal 
conditions or in the presence of insulin are not 
identified, all protein kinases tested were inhibited 
by amiloride. Of those tested, cyclic AMP- 
dependent protein kinase, the calmodulin- 
dependent glycogen synthase kinase, glycogen syn- 
Chase kinase-5 and casein kinase-1 all phosphor- 
ylate purified rat mammary ATP-citrate lyase in 
vitro [lo; P.S. Guy, D.G.H. and J.R.W. (1983) 
unpublished]. In at least one case (cyclic AMP- 
dependent protein kinase) the inhibition was 
shown to be competitive with respect o ATP. Ex- 
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Fig.2. Structure of amiforide. 
amination of the structure of amiloride (fig.2) 
reveals that it has a heterocyclic ring structure not 
unlike that of purines and pyrimidines. Amiloride 
may therefore inhibit protein kinases by competing 
at the ATP binding site. 
Our results also cast doubt on conclusions 
drawn from experiments with amiloride on CC139 
cells [8]. It was claimed that the inhibition of 
phosphorylatio~ of ribosomal protein S6 by 
amiloride was due to a change in intracellular pH 
brought about by inhibition of Na+fH+ exchange 
at the plasma membrane. However, inspection of 
their data suggests that > 0.1 mM amiloride is re- 
quired to produce significant inhibition of S6 
phosphorylation, whereas the IDSO for the effect of 
amiloride on Na+-dependent proton extrusion was 
3 ,uM [8]. In isolated hepatocytes the X&O for 
amiloride on phosphorylation of cytosolic proteins 
ranges from 2-S mM [9]. Our data suggest that the 
inhibition of phospho~lation of ribosomal protein 
S6 in CC1 39 cells by amiloride could be a direct ef- 
fect on protein kinase activity and may be indepen- 
dent of the effects of the drug on Na’/H’ 
exchange. 
Although we were unable to detect an effect of 
insulin treatment of isolated hepatocytes on the 
activity of protein phosphatases 1, 2A or 2C 
measured in cell extracts, we cannot rule out the 
possibility that an effect of insulin on one of these 
protein phosphatases i lost on preparation of the 
extract. Whether insulin stimulates phosphoryla- 
tion of ATP-citrate lyase and the tw, 46000 
poI~eptide by activating a protein kinase or in- 
hibiting a protein phosphatase remains in our view 
an open question. 
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